###  forms
- Vitamin K1
- Vitamin K2
- Active form: vitamin K hydroquinone
- Inactive precursors (provitamins): none
### Functions
- Activation occurs via enzyme epoxide reductase.
- Mutations in the VKORC1 (Vitamin K epOxide Reductase Complex subunit 1) gene impair the reduction of vitamin K epoxide, resulting in deficiencies in vitamin K-dependent clotting factors.
- Cofactor for γ-carboxylation of glutamate residues on vitamin-K-dependent proteins involved in:
	- Coagulation: II, VII, IX, X, [[Protein C]] and [[Protein S]]
	- Bone formation: osteocalcin (bone Gla protein), matrix Gla protein

### Causes
- Neonatal deficiency due to sterile intestine
- Vitamin K antagonists
- Broad spectrum antibiotic therapy
- [[Malabsorption syndrome]] 

### Presentation
- Hemorrhage (e.g., petechiae, ecchymoses) 
- Vitamin K deficiency bleeding (VKDB) 
	- ↑ PT and aPTT, normal bleeding time
	- Postnatal prophylaxis: vitamin K injection at birth

### Vitamin K toxicity
- Toxicity is very rare.
- Cause: oversupplementation
- Clinical features
- Hemolytic anemia
- Hyperbilirubinemia
- Jaundice
- Kernicterus in infants
### Therapeutic uses
- Postnatal vitamin K injection to prevent VKDB
- Coagulopathy: disorders of the extrinsic pathway of coagulation.